Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125314461 | 12531446 | 1 | I | 20160412 | 20160706 | 20160706 | PER | US-MALLINCKRODT-T201601383 | MALLINCKRODT | 0.00 | M | Y | 86.00000 | KG | 20160706 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125314461 | 12531446 | 1 | PS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | 25MCG/HR Q48H | UNKNOWN | 77154 | TRANSDERMAL PATCH | ||||||||
| 125314461 | 12531446 | 2 | I | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | 50MCG/HR Q48H | UNKNOWN | 77154 | TRANSDERMAL PATCH | ||||||||
| 125314461 | 12531446 | 3 | I | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | 75MCG/HR Q48H | UNKNOWN | 77154 | TRANSDERMAL PATCH | ||||||||
| 125314461 | 12531446 | 4 | I | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | 100MCG/HR Q48H | UNKNOWN | 77154 | TRANSDERMAL PATCH | ||||||||
| 125314461 | 12531446 | 5 | I | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | 75MCG/HR Q48H | UNKNOWN | 77154 | TRANSDERMAL PATCH | ||||||||
| 125314461 | 12531446 | 6 | I | Oxycodone | OXYCODONE | 1 | Oral | 2 TABLETS Q 4-6 HOURS (NOT TO EXCEED 7/DAY) | U | UNKNOWN | 0 | TABLET | |||||||
| 125314461 | 12531446 | 7 | I | Oxycodone | OXYCODONE | 1 | U | 0 | TABLET | ||||||||||
| 125314461 | 12531446 | 8 | I | Oxycodone | OXYCODONE | 1 | U | 0 | TABLET | ||||||||||
| 125314461 | 12531446 | 9 | I | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | ||||||||||||
| 125314461 | 12531446 | 10 | I | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | ||||||||||||
| 125314461 | 12531446 | 11 | C | COUMADIN | WARFARIN SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125314461 | 12531446 | 1 | Pain |
| 125314461 | 12531446 | 2 | Nerve injury |
| 125314461 | 12531446 | 6 | Pain |
| 125314461 | 12531446 | 7 | Nerve injury |
| 125314461 | 12531446 | 8 | Breakthrough pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125314461 | 12531446 | Drug ineffective | |
| 125314461 | 12531446 | Dysgeusia | |
| 125314461 | 12531446 | Hyperhidrosis | |
| 125314461 | 12531446 | Insomnia | |
| 125314461 | 12531446 | Product adhesion issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125314461 | 12531446 | 1 | 2011 | 0 | ||
| 125314461 | 12531446 | 5 | 2016 | 0 | ||
| 125314461 | 12531446 | 6 | 2013 | 0 |